DEF 14AThe Ballot
Acrivon Therapeutics, Inc. files DEF 14A
Filed Apr 26, 2024 · 2y ago · Accession 0000950170-24-048671
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Acrivon Therapeutics, Inc.
- Ticker
- ACRV
- CIK
- 1781174
- Form type
- DEF 14A
- Filing date
- Apr 26, 2024
- Report date
- Jun 20, 2024
- Document
- 2024_proxy_statement.htm
- Size
- 3.1 MB